Torrent Pharmaceuticals is currently trading at Rs. 1950.40, up by 14.95 points or 0.77% from its...
* Torrent Pharma (TRP)’s 1QFY24 financial performance was in line with our estimates. The c...
India's Glenmark Life Sciences reported a near-25% rise in its first-quarter profit on Friday...
Torrent Pharmaceuticals is currently trading at Rs. 1848.30, up by 7.30 points or 0.40% from its ...
Torrent Pharmaceuticals is currently trading at Rs. 1797.70, up by 82.90 points or 4.83% from its...
Torrent Pharmaceuticals is currently trading at Rs. 1516.00, down by 14.50 points or 0.95% from i...
Steady show; margin gain priced in! Result Synopsis Torrent revenues beat expecta...
Its Brazil and India business boost growth; maintaining a Buy With good growth in its brand-na...
Branded business outperforms Torrent Pharma’s (Torrent) Q3FY23 performance beats o...
Torrent Pharmaceuticals is currently trading at Rs. 1666.75, up by 14.50 points or 0.88% from its...
In line 2QFY23; focussed efforts towards Branded Generics Work is in progress to resolve the r...
With healthy growth in its branded business (India, Brazil, RoW) offset by weak Germany and US sa...
In line quarter; D/G to Reduce as TRP digests Curatio acquisition Result Synopsis Torrent P...
Torrent Pharma Ltd Buy Torrent Pharma Ltd @ 1590-1594 CMP 1588.10 Stop Loss 1576...
Pricey Curatio acquisition; synergies to play out in FY25; Buy One of the most expensive deals...
Torrent Pharmaceuticals said that the US FDA issued Form 483 to the company with 3 observations p...
Curatio acquisition to strengthen branded portfolio About the stock: Incorporated in 1959, Tor...
The Rs 6,742 crore revenue Torrent Pharmaceuticals Ltd has inked a definitive agreement to acquir...
Torrent Pharmaceuticals Ltd said on Tuesday it will buy dermatology company Curatio Health ...
Promising outlook for India and Brazil segments The US and Germany remain laggard in overall p...
Torrent Pharmaceuticals is currently trading at Rs. 1545.30, up by 10.25 points or 0.67% from its...
Healthy growth in its branded business; maintaining a Buy Backed by growth in its BGx business...
Steady growth with stable margin Result Synopsis Torrent Pharma reported an improved quarte...
Torrent Pharma is currently trading at Rs. 2905.00, up by 4.10 points or 0.14% from its previous ...
Domestic strength to offset muted US Q4 Our view US business proved a surprise offset with ...
Torrent Pharmaceuticals is currently trading at Rs. 2692.90, down by 467.65 points or 14.80% from...
US drags 3QFY22 earnings; inspections key to a revival Well-placed to sustain outperformance i...
Ultratech Cement Buy Ultratech Cement Ltd @ 7624.00-7632.00 CMP 7630.9...
Torrent Pharmaceuticals is currently trading at Rs. 3127.30, up by 59.85 points or 1.95% from its...
Better show in India/Brazil offset by weak US sales Wait continues for USFDA inspection * ...
India and Brazil support the growth Torrent Pharma’s (Torrent) Q2FY22 performance was la...
Lackluster FY22 in store; await US resolution Our view After US, Germany wobbled in Q2 as c...
Strong margins likely to sustain Torrent Pharma’s (Torrent) Q1FY22 performance was large...
DF on a strong footing; making inroads in Trade Generics US growth revival largely dependent o...
India growth drives steady numbers… About the stock: Incorporated in 1959, Torrent has ...
Our view Torrent seems to have dodged any further erosion in US business particularly when oth...
Key News Ramco Cements Q1 net profit up 46% to Rs 172 cr on growth in sales The Ramco Cemen...
JSW Steel Buy JSW Steel Ltd @ 684.00-686.0 CMP 684.25 TGT 697.50&...
Below are Quote on Pharma companies by Mr. Yash Gupta, Equity Research Associ...
Steady quarter; margins remain strong Torrent Pharma’s (Torrent) Q4FY21 performance was ...
In line numbers; focus on margins, brands to sustain Q4FY21 topline remained subdued with grow...
Steady outperformance in the Branded Generics segment US business at a trough; expect a gradua...
Below are Quote on Torrent Pharma - 4QFY21 by Mr. Yash Gupta Equi...
Result Highlights * Q4 revenue came in at flat YoY vs. estimate of +1% YoY. India business gre...
Steady quarter; debt reduction on track Torrent Pharma’s (Torrent) Q3FY21 per...
Soft quarter; steady outlook Torrent’s Q3 results were a tad below expectation due to a ...
In line numbers; future holds on launch momentum Q3 revenues remained flattish (up 1.5% YoY) ...